Analyst Reco. Veradigm Inc.

Equities

MDRX

US01988P1084

Delayed OTC Markets Other stock markets 15:42:18 02/05/2024 BST			5-day change	1st Jan Change
7.805 ^USD	-0.19%		-1.82%	-25.60%

04-03	Veradigm and Vim Announce Strategic Collaboration to Improve Payer-Provider Collaboration	CI
03-19	Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15	03-19	MT
RBC Halves Price Target on Veradigm to $11 From $22, Keeps Outperform Rating	01-19	MT
Barclays Starts Allscripts Healthcare Solutions With Equalweight Rating, $11 Price Target	01-03	MT
Deutsche Bank Adjusts Veradigm Price Target to $15 From $18, Maintains Buy Rating	12-11	MT
Argus Research Downgrades Allscripts Healthcare Solutions to Hold From Buy	06/07/23	MT
Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $18 From $21, Maintains Buy Rating	30/06/23	MT
Stephens Initiates Allscripts Healthcare Solutions at Equalweight With $13 Price Target	12/04/23	MT
Piper Sandler Downgrades Veradigm to Neutral From Overweight, Adjusts Price Target to $18.50 From $17	01/02/23	MT
JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintains Underweight Rating	18/11/22	MT
Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Price Target to $23 From $22	09/11/22	MT
Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Maintains Buy Rating	07/11/22	MT
Deutsche Bank Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $26, Maintains Buy Rating	06/10/22	MT
KeyBanc Initiates Coverage on Allscripts Healthcare Solutions With Sector Weight Rating	16/09/22	MT
Goldman Sachs Starts Allscripts Healthcare Solutions at Neutral With $21 Price Target	12/07/22	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $17 From $19, Maintains Neutral Rating	10/06/22	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $22 From $19, Maintains Neutral Rating	18/03/22	MT
Deutsche Bank Lifts Allscripts Healthcare Solutions to Buy From Hold, Price Target to $26 From $20	04/03/22	MT
SVB Leerink Adjusts Allscripts Healthcare Solutions' Price Target to $24 from $22, Keeps Outperform Rating	03/03/22	MT
SVB Leerink Upgrades Allscripts Healthcare Solutions to Outperform from Market Perform, Adjusts Price Target to $22 from $19	25/01/22	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $19 From $17, Maintains Neutral Rating	25/01/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Veradigm Inc.

Equities

MDRX

US01988P1084

Analyst Reco.

Filters